Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment

Strahlentherapie und Onkologie

Volumn 174, Issue 12, 1998, Pages 629-632

  Lang, Oliver ^a   Liebermeister, Erhard ^a   Liesegang, Jürgen ^a   Sautter Bihl, Marie Luise ^a  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Glioblastoma; Increased fraction size; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; RADIATION DOSE; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

EID: 0031798132     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03038511     Document Type: Article

References (30)

1. Bamberg M, Hess CF, Kortmann R-D. Zentralnervensystem. In: Scherer E, Sack H, eds. Strahlentherapie: Radiologische Onkologie. Berlin-Heidelberg-New York: Springer, 1996:763-808.
2. Bauman GS, Gaspar LE, Fisher BJ, et al. A prospective study of short-course radiotherapy in poor-prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835-9.
3. Buatti JM, Marcus RB, Mendenhall WM, et al. Accelerated hyperfractionated radiotherapy for malignant gliomas. Int Radiat Oncol Biol Phys 1996;34:785-92.
4. Castro JR, Gademann G, Collier JM, et al. Strahlentherapie mit schweren Teilchen am Lawrence Berkeley Laboratory der Universität Kalifornien. Strahlenther Onkol 1987;163:9-16.
5. EORTC Brain Tumor Group. Evaluation of CCNU, VM26 plus CCNU, procarbazine in supratentorial gliomas. Final evaluation of a randomized study. J Neurosurg 1981;55:2731-7.
6. Gannett D, Stea B, Lul, BB, et al. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 1995;33:461-8.
7. Goodman GB, Skarsgard LD, Thompson GB, et al. Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study. Radiother Oncol 1990;17:21-8.
8. Griffin BR, Berger MS, Laramore GE, et al. Neutron radiotherapy of malignant gliomas. Am J Clin Oncol 1989;12:311-5.
9. Halperin EC, Herndon J, Schold SC Jr, et al. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. Int J Radiat Oncol Biol Phys 1996;34:793-802.
10. Haritz D, Gabel D, Huiskamp R. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int J Radiat Oncol Biol Phys 1994;28: 1175-81.
11. Hinkelbein W, Bruggmoser G, Schmidt M, et al. Die Kurzzeitbestrahlung des Glioblastoms mit hohen Einzelfraktionen. Strahlentherapie 1984;160: 301-8.
12. Hinkelbein W, Hempel M, Gilsbach J, et al. Die Kurzzeitbestrahlung des Glioblastoms: Akzelerierte Superfraktionierung versus hohe Einzelfraktionen. In: Bamberg M, Sack H, eds. Therapie primärer Hirntumoren. München-Bern-Wien: Zackschwert, 1988:122-5.
13. Jeremic B, Grujicic D, Antunovic V, et al. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase-II study. Am J Clin Oncol 1995;18:449-53.
14. Kaplan EL, Meyer P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Kriester A, Kloetzer K-H, Kob D. Zur Dosis-Zeit-Optimierung in der fraktionierten Strahlentherapie. Strahlenther Onkol 1988;164:459-98.
16. Krishnasamy S, Vokes EE, Dohrmann GJ, et al. Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme [see comments]. Cancer Invest 1995;13:53-9.
17. Levin VA, Silver P, Hannigan J, et al. Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6C61 final report. Int J Radiat Oncol Biol Phys 1990;18:321-4.
18. Nelson DF, Diener-West M, Weinstein A, et al. A randomized comparison of misonidazole-sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant gliomas after surgery: Final report of an RTOG study. Int J Radiat Oncol Biol Phys 1986;12:1793-800.
19. Noltenius H. Glioblastom. In: Noltenius H, ed. Tumor Handbuch. Klinik und Pathologie der menschlichen Tumoren. Munchen-Wien-Baltimore: Urban & Schwarzenberg, 1987.
20. Ortiz Urbina D de, Santos M, Garcia-Berrocal I, et al. Intraoperative radiation therapy in malignant glioma: early clinical results. Neurol Res 1995;17:289-94.
21. Riva P, Arista A, Sturiale C, et al. Glioblastoma therapy by direct intralesional administration of I-131 radioiodine-labeled antitenascin antibodies. Cell Biophys 1994;37:24-5.
22. Salazar OM, Rubin P, Feldstein ML, et al. High-dose radation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys 1979;5:1733-40.
23. Sautter-Bihl M-L, Barcsay E, Liebermeister E, et al. Strahlentherapie des Glioblastoms: Ist eine Verkürzung der Behandlungszeit vertretbar? Strahlenther Onkol 1991;167:7-13.
24. Schiffer LM. Cell proliferation in tumors and in normal tissue. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1987:57-65.
25. Seegenschmiedt MH, Feldmann HJ, Wust P, et al. Hyperthermia - Its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors. Strahlenther Onkol 1995;171:560-72.
26. Sheline GE, Wara MW, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-28.
27. Slotman BJ, Kralendonk JH, Alphen HA van, et al. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Radiat Oncol Biol Phys 1996;34:895-8.
28. Snelling L, Miyamoto CT, Bender H, et al. Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas. Hybridoma 1995;14:111-4.
29. Wagner W, Schuller P, Willich N, et al. Intraoperative Strahlentherapie (-IORT) maligner Hirntumoren. Strahlenther Onkol 1995;171:154-64.
30. Werner-Wasik M, Scot, CB, Nelson DF, et al. Final report of a phase-I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with sapratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996;77:1535-43.